placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Vessel Sealing / LigaSure™ Maryland Jaw Thoracic Sealer/Divider with Nano-coating

You are entering HCP content only

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

Overview

Reliable vessel-sealing technology

Tailored for Thoracic Surgery

The LigaSure™ Maryland jaw thoracic sealer/divider is part of our commitment to transforming lung care.

It’s the first — and only — minimally invasive LigaSure™ device designed for VATS procedures and indicated for sealing pulmonary veins and arteries up to and including 7 mm.1–5,6

The multifunctional LigaSure™ Maryland jaw thoracic device complements thoracic procedures by providing:

  • One-step vessel sealing7
  • Enhanced blunt dissection8,9,†
  • Secure, atraumatic grasping8,9,†
  • Cold cutting independent of sealing7,8


The LigaSure™ Technology Difference

Reliable LigaSure™ vessel-sealing technology drives the LigaSure™ thoracic device. It works by using the body’s own collagen and elastin to create a permanent seal that is designed to withstand three times normal pulmonary systolic blood pressure.3

Plus, LigaSure™ technology eliminates the guesswork — and minimizes thermal spread8,10,‡ — by automatically discontinuing energy delivery when the seal cycle is complete.11

LigaSure™ Vessel Sealing Technology

Learn more about the technology behind the products.

Learn More
Order Information
Product Code Description Unit of Measure Quantity
LF1930T LigaSure™ Maryland Jaw Thoracic Sealer/ Divider (30 cm) Box 6
Specifications
Generator Compatibility Valleylab™ FT10 Energy Platform

Order Information

Product Training & Support

Access product guides and other product support.

Learn More
  • † 31 of 33 surgeons surveyed after use agreed. Compared to straight jaws.
  •  ‡ Based on systemic vasculature. Compared to Olympus Thunderbeat™*.
  • 1. Based on internal report #RE00138840, LIG-45 memo, device length recommendation, thoracic (LF1930T). Feb. 6, 2018.
  • 2. Based on internal test report #RE00125866, Jaw range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on tissue. Nov. 20–21, 2017 and Nov. 27–30, 2017.
  • 3. Based on internal test report #RE00134865, Burst pressure verification of pulmonary veins (LF1930T). Jan. 17–18, 2018.
  • 4. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.
  • 5. Based on internal test report #RE00128442, GLP Acute pulmonary vasculature hemostasis verification study of the LF1930T in hounds. Dec. 8, 2017.
  • 6. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.
  • 7. LigaSure™ Maryland jaw thoracic sealer/divider one-step sealing, nano-coated [instructions for use]. Boulder, CO: Medtronic; 2018.
  • 8. Based on internal test report #RE00140529 rev A,  LigaSure™ Maryland device, nano-coated (LF19XX) tissue testing (memo). March 5, 2018.
  • 9. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
  • 10. Based on internal report # R0047634_A, Comparison of various competitor devices versus the Sonicision™ device and LigaSure™ LF1637 and LF1737 devices; acute porcine study. Nov. 11 and 18, 2013, and Dec. 9, 2013.
  • 11. Based on internal test report #RE00025819 rev A, LigaSure™ device data sources for VLFT10 white papers. September 2015.
Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2025 Medtronic